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Quantitative analysisAbstract A simple, cost-effective and environmental friendly analytical method was developed for
the quantiﬁcation of erythromycin in tablet formulation using transmission Fourier Transform
Infrared (FT-IR) spectroscopy for routine quality control analysis. There is no need of sample prep-
aration except pellet formation for FT-IR analysis. Use of solvent was totally avoided in this
method. Calibration was carried out by using simple Beer’s law in the FT-IR region between
1743 and 1697 cm1. The excellent coefﬁcient of determination (R2 = 0.998) was achieved with
0.0247 and 1.14 root mean square error of prediction (RMSEP) and root mean square error of cross
validation (RMSECV), respectively. The results of the study revealed that the transmission FT-IR
spectroscopy could be effectively used for rapid determination of active ingredients like erythromy-
cin in pharmaceutical formulations to control the quality of ﬁnished products.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Erythromycin is a broad-spectrum macrolide antibiotic pro-
duced by a strain of Streptomyces erythreus (Amin and Issa,
1996). Structurally, erythromycin is a 14-membered lactone
ring (Fig. 1) with ten asymmetric centers and two sugar mole-
cules (L-cladinose and D-desoamine). It seems to be very difﬁ-
cult to produce erythromycin synthetically. Patients allergic toPenicillin are often treated with erythromycin due to its antimi-
crobial activity almost similar or slightly wider than Penicillin
(Norouzi et al., 2009). It is also a very effective antibacterial
drug often used for the treatment of pneumonia, throat, bron-
chitis and ear infections, as well as respiratory and urinary
tract infections (Avramov Ivic et al., 2008).
A number of analytical techniques such as ultraviolet (UV),
high performance liquid chromatography (HPLC), capillary
electrophoresis, various electrochemical detections, near infra-
red (NIR) and liquid chromatography/mass spectrometry (LC/
MS) have been applied for the determination and qualitative
analysis of erythromycin in raw materials, dosage forms and
biological samples. It is difﬁcult to achieve high sensitivity with
UV detection because erythromycin lacks a UV chromophore
(Deubel et al., 2006). UV method has been developed for the
determination of erythromycin by formation of a blue-colored
complex with gentian violet in alkaline medium (Amin and
Figure 1 Chemical structure of erythromycin.
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amount of solvents and costly reagents for derivatization to
achieve better sensitivity as a few methods are reported (Tor-
ano and Guchelaar, 1998; Weitao et al., 2005). Then, capillary
electrophoresis (CE) coupled with end-column electro chemilu-
minescence (ECL) detector for determination of erythromycin
has also been used (Biyang et al., 2007) but CE has not been
used widely in the pharmaceutical laboratories. Compara-
tively, being cheaper and faster than chromatography, electro-
chemical methods using the oxidation behavior for the
determination of erythromycin with various types of electrodes
have been reported (Norouzi et al., 2009; Avramov Ivic et al.,
2008; Nagwa et al., 2004; Huaisheng et al., 2000; Yudi et al.,
1993). The use of NIR spectroscopy for the determination of
erythromycin by dissolving in the suitable solvent and also in
solid state has been also described (Qu et al., 2007; Yan and
Chang, 2006). Almost all of these established analytical meth-
ods are complicated, laborious and time consuming (Ventura
et al., 2006). Furthermore, these require dissolution of the sam-
ples in the proper solvents and then often extraction is per-
formed with organic solvents which are toxic to human
health and environment. The pharmaceutical regulatory
authorities for good manufacturing practices (GMP) always
entail accurate and rapid analysis of ﬁnished pharmaceutical
products, such as tablets and capsules, to quantify the active
ingredient (Moros et al., 2007). However, with the FT-IR spec-
troscopy, the spectra could be recorded without any apprecia-
ble pretreatment. The FT-IR group of National Centre ofFigure 2 FTIR spectra of erythromycin standaExcellence in Analytical Chemistry (NCEAC) has already
developed the methods using FT-IR spectroscopy for the
determination of different quality parameters of oils and fat
(Sherazi et al., 2007, 2009, 2011; Van.De voort et al., 2008).
The main objective of the present study was the development
of a rapid, cheap and environment friendly analytical method
for the determination of Erythromycin in tablet formulations
for routine quality control analysis, based on transmission
FT-IR spectroscopy without using any solvent.2. Experimental
2.1. Reagents and samples
Analytical grade Erythromycin (98%) used for calibration in
the present study was obtained from Sigma Aldrich. Spectro-
scopic grade KBr was used for the preparation of sample pel-
lets. The different commercially available tablet samples
containing Erythromycin as an active ingredient were pur-
chased from medical stores of local markets.
2.2. FT-IR spectral measurements
For the acquisition of infrared spectra of standards as well as
samples in the tablet form, Thermo Nicolet 5700 FTIR spec-
trometer equipped with removable KBr optics and deuterated
triglycine sulfate (DTGS) detector was used. The instrument
was controlled by commercially available IR spectra analysis
software package OMNIC (Thermo Nicolet Analytical Instru-
ments, Madison, WI). All spectra were recorded averaging 32
scans in the range of 4000–400 cm1 at a resolution of 4 cm1.
The spectrum of each standard as well as sample was ratioed
against a fresh background spectrum recorded from KBr
pellet.
2.3. FT-IR calibrations
A set of 16 standards of Erythromycin containing the range
between 0.005 and 1.0 mg in KBr was prepared to formulaterds in mid infrared region (4000–400 cm1).
Figure 3 The absorbance of carbonyl band of erythromycin standards in increasing concentrations.
Figure 4 Spectrum A represents the mixture of excipients (i.e. avecil, magnesium stearate, starch and talcum powder) used in solid
erythromycin formulation, spectrum B is erythromycin standard and spectrum C represents Erythromycin tablet sample.
1106 M. Ali et al.the 100 mg pellets of total weight. By the use of Omnic soft-
ware and TQ Analyst program, simple Beer’s law method
was developed for the quantitative determination of Erythro-
mycin in tablet formulations. In the TQ Analyst program
Erythromycin standards spectra ranging from 0.005 mg to
1.0 mg were selected, that were already recorded. Speciﬁc re-
gion of ketone band i.e. 1743–1697 cm1 was speciﬁed in the
TQ Analyst program, 2004 (Thermo Electron Corporation,
Madison WI, USA) for best results. Area under the band for
all Erythromycin standards was calculated by the softwarepackage itself which saved plenty of time and labor to compute
the band area of each standard. A very good calibration was
also generated with excellent regression using the TQ Analyst
software.2.4. Sample preparation procedure
In this method no prior sample preparation is required for
FTIR run except grinding. The tablet samples were weighed
Figure 5 TQ analyst calibration of erythromycin standards.
Table 1 Results for the erythromycin in the tablet
formulations.
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size. The KBr pellets were prepared by mixing 1 mg samples
with 99 mg of dried, ﬁnely powdered potassium bromide then
condensed in the 13-mm die at a pressure of 6 tons for 5 min.
The pellets were scanned from 4000 to 400 cm1 on Thermo
Nicolet 5700-FTIR spectrometer.
2.5. Limit of detection and quantiﬁcation
For the determination of limit of detection (LOD) and limit of
quantiﬁcation (LOQ) of the proposed method, the selected
band area was measured at low concentrations of standards,
until the erythromycin related signal disappeared. The analysis
at the lowest amount which produced substantial signal was
repeated eleven times and calculated by the following formula
(Memon et al., 2010):
LOD ¼ 3 SD C=M
where: SD is the standard deviation; C is the concentration of
analyte and M is the mean band area.
While LOQ was determined by the same way with the fol-
lowing equation:
LOQ ¼ 10 SD C=M
Sample Erythromycin
labeled mg/Tablet
Erythromycin
found mg/Tablet
Sample 01 500 489.81 ± 0.642
Sample 02 500 492.54 ± 0.394
Sample 03 500 497.66 ± 0.056
Sample 04 250 253.17 ± 0.472
Sample 05 250 246.5 ± 0.0852.6. Recovery efﬁciency
The recovery efﬁciency (RE) was determined by the ratio of
erythromycin recovered (%) to the erythromycin content
(mg) added. The calculation was carried out by the following
equation:R ð%Þ ¼ ðC B=AÞ  100
where, R is the erythromycin recovered (%), (B) is actual con-
centration present in the sample before addition of erythromy-
cin (C) is the concentration of erythromycin after addition and
(A) added level of erythromycin.
The CV (%) of the data set was calculated and used as rel-
ative standard deviation (RSD, %) as in the AOAC Guidelines
for Single Laboratory Validation of Chemical Methods for
Dietary Supplements and Botanicals (AOAC International,
2002).
3. Results and discussion
The results of this study accomplish signiﬁcant beneﬁts in
terms of rapidity, accuracy, simplicity and green method by
the use of FTIR spectroscopy for measuring quantity of the
desired active species while performing quality control of phar-
maceuticals. Fig. 2 represents the transmission FTIR spectrum
Table 2 Recovery test of erythromycin from tablet samples after exogenous addition of known amount of standards.
By FT-IR Acceptable recovery(%)
(A) (B) (C) Recoverya(%) CVb(%) (AOAC, 2002)
1 25 246.5 270.81 ± 0.21 97.24 0.83 90–108
2 50 246.5 296.43 ± 0.16 99.86 0.75
3 100 246.5 348.26 ± 0.28 101.76 1.03
(A) Exogenous addition.
(B) Before addition.
(C) After addition.
a Recovery (%) = (C  B)/A · 100.
b Coefﬁcient of variation was obtained from the mean of triplicate tests.
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form of KBr pellets. The homogenous composition was
achieved by carefully measuring speciﬁc amounts of the eryth-
romycin standard and KBr ratio by applying equal pressure
for all pellets.
Fig. 3 speciﬁcally shows the absorbance of the carbonyl
(C‚O) band of erythromycin standard (0.005 to 1.0 mg) in
the FTIR region between 1743 and 1697 cm1. The carbonyl
band was selected for the quantiﬁcation of erythromycin due
to the well established fact that no excipients exhibit absorp-
tion in this region.
Other bands appearing at 2980 to 2900 cm1, 2860 to
2840 cm1 and 1480 to 1440 cm1 have some interfering bands
appearing in the same region due to the mixture of the excip-
ients present in the formulation. The excipients commonly
used in the solid commercial formulation of erythromycin
are starch, magnesium stearate, lactose, avecil and talcum
powder. FT-IR spectra of mixed excipients are shown in
Fig. 4A. The main idea of the achieving green method was
fully achieved in the sense that strategy of avoiding extraction
brought overwhelming success as clearly shown in the ﬁgure
that two spectra i.e. sample and the erythromycin standard
both spread over the surface of each other and there is no sig-
niﬁcant interference bands hence proving the method to be
practical.
A simple Beer’s law quantitative model based upon the
measurement of the band area of the selected region was ap-
plied for the quantitative determination of erythromycin in
the pharmaceutical formulations using a speciﬁed region and
a good calibration curve with a linear regression of 0.998 as
quoted in Fig. 5 was achieved. The slope and intercept were
determined corrected with one point baseline, and then the ob-
tained regression equation was used for the calculation of
erythromycin concentration in the tablets. The % difference
plot between the actual and calculated values for the calibra-
tion standards is also shown in the ﬁgure. The calibration
clearly shows the tremendous sensitivity of transmission
FT-IR spectroscopy for the determination of erythromycin
in the pharmaceutical formulation in the form of tablets.
From the calibration, the assessment of the errors was car-
ried out by calculating the residual mean standard error of cal-
ibration (RMSEC) after comparing the actual concentration
with the computed one for each component with the standard
deviation of 0.158. The root mean square error of prediction
(RMSEP) was 0.0247. The quantitative model was also veriﬁed
through root mean square error of cross validation
(RMSECV) which was found to be 1.14.Y ¼ 8:09xþ 0:00
The regression equation obtained from the calibration of
standards was afterwards utilized for the calculation of the
concentration of erythromycin active in the real samples.
The summary of the results obtained by the proposed method
for erythromycin tablets is presented in Table 1. The concen-
tration of erythromycin determined was found to be in the
range of 97.96–101.26% with labeled contents in analyzed tab-
let samples and is within the permissible limits of the
pharmacopoeia.
The statistics of erythromycin recovery tests (Table 2) on
the one selected tablet sample revealed high recovery perfor-
mance (97.24, 99.86 and 101.76 %) with high precision
(%CV= 0.83, 0.75, and 1.03) of the proposed method. Satis-
factory recovery is 90–108% (AOAC International, 2002). The
% recovery results revealed that there is no signiﬁcant interfer-
ence effect from any other constituent present in the matrix
and hence prove that this method is feasible without any sol-
vent extraction. LOD and LOQ calculated for this method
were found to be 0.006 mg g1 and 0.018 mg g1 respectively.
These results clearly prove the validity of the proposed method
using transmission FT-IR spectroscopy for quantitative
analysis.4. Conclusion
The proposed method for the determination of erythromycin
in tablets using FTIR spectroscopy for quality control analysis
is a straightforward analytical method which is very simple as
it does not require any complex procedure. This is an econom-
ical and environmentally friendly method avoiding the use of
hazardous chemicals or solvents and could be effectively used
in the pharmaceutical industry for GMP as a rapid and green
method. This may be applied as a capable method for the spee-
dy quality assessment/quality control (QA/QC) of the active
ingredients like erythromycin in the pharmaceutical
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